Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function
- PMID: 17618750
- DOI: 10.1016/j.ajog.2007.02.015
Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function
Abstract
Objective: This study was undertaken to compare the effects of exposure to repeated courses of antenatal steroids with those of a single course on hypothalamic-pituitary-adrenal axis function.
Study design: Women at risk of premature delivery were assessed for entry into a randomized controlled trial of repeated courses of corticosteroids (ACTORDS). If a woman declined the randomized trial then consent was sought for collection of observational data. Baseline bloods for cortisol and adrenocorticotropic hormone levels were collected and in a subset of infants a metyrapone test performed.
Results: In the 86 studied infants, cortisol and adrenocorticotropic hormone levels did not differ between those exposed to single and repeated courses of antenatal steroids (P = .53 and P = .15, respectively). Although cortisol levels fell in response to metyrapone (P = .03) this response was not different between the single and repeated course groups (P = .46).
Conclusion: Repeated courses of antenatal steroids do not cause important hypothalamic-pituitary-adrenal axis suppression in the neonate.
Comment in
-
Antenatal steroid treatment: suppression with no impairment of the adaptive function of the HPA-axis in newborns at birth.Am J Obstet Gynecol. 2008 May;198(5):606; author reply 606-7. doi: 10.1016/j.ajog.2008.01.018. Epub 2008 Mar 24. Am J Obstet Gynecol. 2008. PMID: 18359476 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
